Iferra Tablet is a combination formulation containing Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg, and Zinc 22.5 mg, designed to address iron deficiency anemia and support overall hematologic health. Ferrous Ascorbate serves as a bioavailable source of elemental iron, essential for hemoglobin synthesis and oxygen transport in the blood. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis, red blood cell formation, and prevention of megaloblastic anemia. Zinc, an essential trace element, contributes to immune function, wound healing, and cellular metabolism. Iferra Tablet is indicated for the prevention and treatment of iron deficiency anemia, particularly in populations with increased iron requirements such as pregnant and lactating women, adolescents, and individuals with nutritional deficiencies. The combination enhances iron absorption and utilization while supporting hematopoiesis and immune competence. Administration should follow medical advice, with consideration of potential contraindications such as hemochromatosis or hypersensitivity to any component. Common adverse effects may include gastrointestinal discomfort, nausea, or constipation, which can be minimized by taking the tablet with food. Regular monitoring of hematologic parameters is recommended during therapy to assess efficacy and safety. Iferra Tablet offers a comprehensive approach to managing iron deficiency and related nutritional deficits, promoting improved patient outcomes.